Your institution may have access to this item. Find your institution then sign in to continue.
Title
Standard-dose efavirenz vs. standard-dose nevirapine in antiretroviral regimens among HIV-1 and tuberculosis co-infected patients who received rifampicin.
Authors
Manosuthi, W; Mankatitham, W; Lueangniyomkul, A; Chimsuntorn, S; Sungkanuparph, S
Abstract
There is limited comparative data between efavirenz (EFV) 600 mg/day and nevirapine (NVP) 400 mg/day-based antiretroviral therapy (ART) among HIV-1 patients with tuberculosis (TB) and receiving rifampicin.